CVS Group (LON:CVSG) Hits New 52-Week High – Time to Buy?

Shares of CVS Group plc (LON:CVSG – Get Free Report) reached a new 52-week high on Monday. The stock traded as high as GBX 1,432 and last traded at GBX 1,423, with a volume of 21,952 shares traded. The stock had previously closed at GBX 1,412.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Jefferies Financial Group reiterated a “hold” rating and set a GBX 1,400 price objective on shares of CVS Group in a report on Friday, September 25th. Berenberg Bank restated a “buy” rating and issued a GBX 2,000 target price on shares of CVS Group in a research note on Thursday, September 24th. Shore Capital Group reaffirmed a “hold” rating and set a GBX 1,400 price target on shares of CVS Group in a research report on Thursday, September 24th. Finally, Deutsche Bank reaffirmed a “buy” rating and set a GBX 1,700 price target on shares of CVS Group in a research note on Monday, July 27th. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of GBX 1,666.67.

View Our Latest Research Report on CVS Group

CVS Group Stock Up 0.8%

The company has a current ratio of 1.18, a quick ratio of 0.90 and a debt-to-equity ratio of 110.41. The firm’s 50 day simple moving average is GBX 1,285.08 and its 200-day simple moving average is GBX 1,255.45. The stock has a market capitalization of £949.58 million, a price-to-earnings ratio of 58.59, a price-to-earnings-growth ratio of 1.77 and a beta of 1.04.

CVS Group (LON:CVSG – Get Free Report) last posted its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 EPS for the quarter. CVS Group had a net margin of 2.43% and a return on equity of 5.91%. Equities analysts expect that CVS Group plc will post 93.94 earnings per share for the current fiscal year.

CVS Group Company Profile

(Get Free Report)

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

Further Reading

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.